Neuropathy;Peripheral Clinical Trial
Official title:
Investigating Mechanisms Underlying Spinal Cord Stimulation Efficacy Using Virtual Reality and Full Body Illusion
The study hypothesis is that spinal cord stimulation (SCS) combined with virtual leg illumination (provided through a wearable headset (OculusRift, OculusVR, Irvine, CA) and a custom-designed virtual reality leg scenario) will lead to controlled analgesia induction, boosting analgesic effects obtained with standard SCS treatments and will further be associated with changes in the perception of the affected body part.
Epidural spinal cord stimulation (SCS) is an approved treatment for truncal and extremity neuropathic pain. The mechanisms underlying the efficacy of SCS are unknown. Recent advances in cognitive neuroprosthetics using virtual reality allow for modulation of body perception and bodily experience, which has also been shown to modulate pain perception. The present research proposal plans to merge expertise in cognitive neuroprosthetics with neuromodulation techniques in order to test the analgesic properties of the combination of epidural spinal cord stimulation with a new system of multisensory stimulation based on virtual and enhanced reality (i.e., neuro-visual stimulation). The investigators propose to study this hypothesis prospectively in 25 patients with implanted SCS systems for the treatment of chronic neuropathic pain. Primary outcomes will be pain reduction (based on subjective, functional and physiological measures) and changes in body perception (based on subjective and objective measures). The present study will generate a proof-of-concept for the application of neuro-visual stimulation for the treatment of chronic pain and will form the basis for future NIH funding application. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04699734 -
Peripheral Nerve Block in Patients With Painful Diabetic Polyneuropathy
|
N/A | |
Completed |
NCT04054804 -
Digital Foot Check by Using the D-Foot, a New Software
|
||
Completed |
NCT05161364 -
Kinetic Analysis Due to Foot Dysfunction
|
||
Not yet recruiting |
NCT03899298 -
Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions
|
Phase 1 | |
Recruiting |
NCT05291286 -
BXQ-350 Pharmacokinetic/Pharmacodynamic Study in Cancer Patients
|
Early Phase 1 | |
Recruiting |
NCT04403802 -
Voxx Human Performance Technology Socks for Chemotherapy-Induced Peripheral Neuropathy
|
N/A | |
Enrolling by invitation |
NCT05590117 -
Protective Effect of Pentoxifylline Against Chemotherapy Induced Toxicities in Patients With Colorectal Cancer
|
Early Phase 1 | |
Recruiting |
NCT05624138 -
The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy
|
Phase 3 | |
Recruiting |
NCT06121232 -
Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study
|
N/A | |
Recruiting |
NCT05065554 -
ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy
|
Phase 2 | |
Recruiting |
NCT05980767 -
Short Duration Electrical Stimulation to Improve Outcomes After Cubital Tunnel Release (SELECT) Trial
|
N/A | |
Completed |
NCT03135535 -
Micro-mobile Foot Compression and Diabetic Foot
|
Phase 2 | |
Recruiting |
NCT03037684 -
Depolarising Electrical Skin Stimulation in Neuropathic and Postoperative Pain
|
||
Recruiting |
NCT04865185 -
Effect of Topical Lidocaine on Warm and Cold Sensation in Healthy Individuals
|
N/A | |
Completed |
NCT05093023 -
ABCB1 SNPs as Predictors of PIPN
|
||
Completed |
NCT05410548 -
Comorbidity Screening and Referral by Prosthetists
|
N/A | |
Completed |
NCT03021174 -
Exercise and Nutrition Interventions During Chemotherapy
|
N/A | |
Not yet recruiting |
NCT06422949 -
Efficacy and Safety of HILOTERM® Device for the Prevention of Peripheral Neuropathy
|
N/A | |
Terminated |
NCT03777956 -
The Effect of Lacosamide in Peripheral Neuropathic Pain
|
Phase 2 | |
Terminated |
NCT04218448 -
Evaluation of the Interest of Hypno-relaxation During Somatosensory Evoked Potentials
|
N/A |